Navigation Links
Viral Genetics Creates Subsidiary to Develop Cancer Therapy
Date:8/7/2009

SAN MARINO, Calif., Aug. 7 /PRNewswire-FirstCall/ -- Biotechnology company Viral Genetics (Pink Sheets: VRAL) has formed a wholly owned subsidiary called MetaCytoLytics, Inc. This company was created to advance a technology developed by University of Colorado Professor M. Karen Newell called "metabolic disruption technology" (MDT), which focuses on blocking a tumor cell's ability to generate energy from glucose or from fatty acids. That process has been found in animal studies to not only directly cause cancer cells to die but also to synergize with existing treatments such as chemotherapy and radiation therapy to further limit the growth of tumor cells. Dr. Richard J. Trauger, Ph. D., will be chief executive officer of the new company. He will focus on bringing this concept forward into clinic trials and expanding the indications provided by the technology platform.

"The potential for this technology platform is quite exciting," said Dr. Trauger. "Metabolic disruption is a concept that has tantalized cancer researchers for decades. We believe that we finally have the knowledge and tools to turn this concept into a clinical reality."

Dr Karen Newell and her team at the University of Colorado at Colorado Springs have performed over 400 metabolic disruption technology experiments with a large panel of disrupting compounds for proof of principal--either in vitro or in animal models. Dr. Newell, who has been on the cutting edge of metabolic disruption of tumor cells for many years helped develop the process for Viral Genetics.

"The results are consistently supportive that metabolic disruption, in combination with conventional therapies, is very promising for combating drug resistant tumors," said Dr. Newell.

Prior to joining MetaCytoLytics, Inc., Dr. Trauger was the senior director for infectious disease and cancer at Hollis Eden Pharmaceuticals
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances
2. Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
3. New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance
4. BIO Visitors Bring Viral Preparedness to Atlanta
5. Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
6. INFORM-1 Clinical Trial Amended to Further Explore Promising Direct Antiviral Regimen in HCV Patients
7. Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray
8. Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
9. Researchers decode viral process that prepares cells for HIV infection
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 Research presented at the 2015 ... on the studies that led to a fingerprick Ebola ... this disease to receive approval from the World Health ... Ebola,s grip on West Africa ... healthcare workers to isolate and treat these patients much ...
(Date:7/27/2015)... NEW YORK , July 27, 2015 /PRNewswire-USNewswire/ ... today announced the winners of its annual ... basic research by scientists who have been supported ... early career scientists to pursue innovative ideas in ... generate "proof" of concept for the early detection, ...
(Date:7/27/2015)... Princeton Junction, NJ (PRWEB) , ... July 27, 2015 , ... ... Awards, which identify and celebrate the top 100 most innovative technologies and services of ... ® which was named in the Software/Services category. The winners will be announced at ...
(Date:7/24/2015)... Ryan & Maniskas, LLP that a class action ... the Northern District of California on ... stock of Avalanche Biotechnologies, Inc. ("Avalanche" or the "Company") (NASDAQ: ... 2015, inclusive (the "Class Period"). Avalanche shareholders may, ... appointment as a lead plaintiff of the Class.  If you ...
Breaking Biology Technology:Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 2Rapid Ebola Test Could Play Key Role in Efforts to End Lingering Outbreak 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 2Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 3Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 4Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 5Brain & Behavior Research Foundation Names Winners of Klerman-Freedman Prizes for Exceptional Research 6Visual Assay® Named Finalist in 53rd Annual R&D 100 Awards 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3
... Sept. 14 Stemedica Cell Technologies, Inc., a world ... today that it has completed its proprietary master bank ... bank was manufactured in accordance with FDA Good Manufacturing ... the necessary safety testing required by the FDA and ...
... Sept. 13 Regenicin™, Inc. ... biotechnology company, announced today that John J. Weber, the ... Systems, USA, Inc. ("Fujifilm USA"), has agreed to join ... directors and interim Chief Financial Officer.  Weber brings over ...
... 13 SOCMA President & CEO Lawrence Sloan will lead ... coming Wednesday morning. The panel will address the "Shifting Landscape ... supply chain, reports Mark Alexay, the organizer. Sloan,s ... and SOCMA,s Bulk Drug Pharmaceutical Task Force. The BPTF was ...
Cached Biology Technology:Stemedica Announces Completion of Clinical Stem Cell Master Bank 2Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO 2
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/13/2015)... OXFORD, Conn. , Jul. 13, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/188684 for ... NXT-ID achieves another new convenient and secure method ... expands new, innovative payment methods, introduced with its ...
(Date:7/9/2015)... Calif. , July 9, 2015 /PRNewswire/ ... leading developer of human interface solutions, today ... the industry,s first fully hardware encapsulated fingerprint ... secure authentication technology is literally off the ... and biometric matching within the fingerprint sensor ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... process used to roast coffee beans could give Britain,s ... some of the UKs leading energy crops by up ... by engineers from the University of Leeds, examined the ... when put through a mild thermal process called torrefaction ...
... Babies born preterm were more than twice as likely to ... new analysis of nearly 7 million U.S. live births published ... Health Journal. Preterm birth, live birth before 37 ... to the March of Dimes. More than a half million ...
... as neurons process information by joining into complex networks, ... But neurons dont just connect to other neurons, emphasizes ... they connect to very specific partners, at particular spots. ... Laboratory (CSHL), leads a team that has identified molecules ...
Cached Biology News:Analysis of millions of US births shows association between birth defects and preterm birth 2Scientists discover a molecular scaffold that guides connections between brain cells 2Scientists discover a molecular scaffold that guides connections between brain cells 3
MHC II (HLA-DP)...
... is a new product number, created to ... no availability yet, please order under the ... service for assistance. ID clarifier: ... H 100 20 mm surface ...
BD BioCoat Laminin 100 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
... 5-OxoETE-d7 is used as an internal ... stable isotope dilution mass spectrometry. 5-OxoETE is ... oxidation of 5-HETE in human neutrophils. It ... an EC50 of 2 nM. 5-OxoETE selectively ...
Biology Products: